Next, we investigated the expression levels of these potential target genes in both HCC and normal groups, we selected a total of 25 HCC expression datasets and found that CHEK2 exhibited significant upregulation in a majority of the HCC datasets (20/23), except for two datasets where it was not detected. The gene discussed is CHEK2; the disease is hepatocellular carcinoma.